BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register
Holdings (Monthly) Guide ↗

iShares Biotechnology ETF

· iShares Trust
Monthly Holdings $8.9B AUM 289 positions Period Mar 2026 Filed May 28, 2026 EDGAR ↗ ← All Funds
All 54 New 196 Added 31 Exited · Mar 2026 vs Sep 2025
# Name Ticker Since Shares Shares Δ Value Val Δ% % Port Cat
1 BlackRock Funds III 066922519 Mar 2026 784,655,767 +1,928,164 $784.8M +0.2% 9.66% STIV
2 Gilead Sciences, Inc. 375558103 Mar 2026 4,515,707 +492,782 $629.4M +40.9% 7.75% EC
3 Amgen, Inc. 031162100 Mar 2026 1,733,148 +153,460 $609.8M +36.8% 7.51% EC
4 Vertex Pharmaceuticals, Inc. 92532F100 Mar 2026 1,354,033 +191,398 $604.6M +32.8% 7.44% EC
5 Regeneron Pharmaceuticals, Inc. 75886F107 Mar 2026 758,232 +156,065 $585.8M +73.0% 7.21% EC
6 Alnylam Pharmaceuticals, Inc. 02043Q107 Mar 2026 979,642 +239,530 $324.1M -4.0% 3.99% EC
7 Insmed, Inc. 457669307 Mar 2026 1,587,887 +369,063 $259.7M +47.9% 3.20% EC
8 Argenx SE 04016X101 Mar 2026 341,883 +88,168 $249.7M +33.4% 3.07% EC
9 Biogen, Inc. 09062X103 Mar 2026 1,091,046 +228,193 $200.0M +65.5% 2.46% EC
10 Natera, Inc. 632307104 Mar 2026 980,622 +200,465 $196.1M +56.2% 2.41% EC
11 United Therapeutics Corp. 91307C102 Mar 2026 315,509 +57,570 $187.1M +73.0% 2.30% EC
12 BeOne Medicines Ltd. 07725L102 Mar 2026 529,143 +161,733 $157.1M +25.5% 1.93% EC
13 Incyte Corp. 45337C102 Mar 2026 1,467,923 +330,295 $138.2M +43.2% 1.70% EC
14 Moderna, Inc. 60770K107 Mar 2026 2,692,459 +666,773 $136.8M +161.4% 1.68% EC
15 Illumina, Inc. 452327109 Mar 2026 1,107,291 +226,312 $136.5M +63.1% 1.68% EC
16 Revolution Medicines, Inc. 76155X100 Mar 2026 1,283,912 +328,618 $124.9M +179.9% 1.54% EC
17 Roivant Sciences Ltd. N/A Mar 2026 3,642,557 +2,694,909 $100.9M +254.9% 1.24% EC
18 Neurocrine Biosciences, Inc. 64125C109 Mar 2026 727,502 +158,564 $95.8M +20.0% 1.18% EC
19 Genmab A/S 372303206 Mar 2026 3,555,098 +884,567 $95.4M +16.5% 1.17% EC
20 Bridgebio Pharma, Inc. 10806X102 Mar 2026 1,238,687 +282,546 $92.0M +85.2% 1.13% EC
21 Ionis Pharmaceuticals, Inc. 462222100 Mar 2026 1,205,549 +273,434 $90.5M +48.5% 1.11% EC
22 Medpace Holdings, Inc. 58506Q109 Mar 2026 169,922 +36,145 $81.6M +18.6% 1.00% EC
23 Madrigal Pharmaceuticals, Inc. 558868105 Mar 2026 155,341 +36,454 $81.3M +49.1% 1.00% EC
24 Exelixis, Inc. 30161Q104 Mar 2026 1,871,326 +334,547 $80.3M +26.5% 0.99% EC
25 BioMarin Pharmaceutical, Inc. 09061G101 Mar 2026 1,412,330 +297,157 $79.8M +32.1% 0.98% EC
26 Ascendis Pharma A/S 04351P101 Mar 2026 339,948 +87,969 $77.8M +55.2% 0.96% EC
27 Praxis Precision Medicines, Inc. 74006W207 Mar 2026 195,097 +78,539 $62.9M +917.5% 0.77% EC
28 Charles River Laboratories International, Inc. 159864107 Mar 2026 362,165 +75,233 $62.5M +39.2% 0.77% EC
29 Arrowhead Pharmaceuticals, Inc. 04280A100 Mar 2026 975,175 +218,405 $61.1M +134.3% 0.75% EC
30 Vaxcyte, Inc. 92243G108 Mar 2026 1,045,695 +305,975 $60.8M +128.1% 0.75% EC
31 Bio-Techne Corp. 09073M104 Mar 2026 1,151,950 +245,468 $60.2M +19.4% 0.74% EC
32 Cytokinetics, Inc. 23282W605 Mar 2026 896,972 +207,023 $59.1M +55.9% 0.73% EC
33 Halozyme Therapeutics, Inc. 40637H109 Mar 2026 868,502 +186,537 $56.1M +12.2% 0.69% EC
34 Axsome Therapeutics, Inc. 05464T104 Mar 2026 319,088 +76,401 $53.9M +83.0% 0.66% EC
35 BioNTech SE 09075V102 Mar 2026 599,506 +227,603 $53.3M +45.3% 0.66% EC
36 Krystal Biotech, Inc. 501147102 Mar 2026 188,966 +42,377 $48.8M +88.6% 0.60% EC
37 Protagonist Therapeutics, Inc. 74366E102 Mar 2026 447,047 +100,457 $47.1M +104.7% 0.58% EC
38 Repligen Corp. 759916109 Mar 2026 396,896 +83,327 $46.8M +11.6% 0.58% EC
39 Kymera Therapeutics, Inc. 501575104 Mar 2026 521,385 +174,201 $43.4M +121.0% 0.53% EC
40 Alkermes plc N/A Mar 2026 1,216,662 NEW $43.0M — 0.53% EC
41 Rhythm Pharmaceuticals, Inc. 76243J105 Mar 2026 474,539 +111,815 $41.3M +12.7% 0.51% EC
42 Abivax SA 00370M103 — 367,461 NEW $40.9M — 0.50% EC
43 PTC Therapeutics, Inc. 69366J200 Mar 2026 593,152 +144,867 $40.4M +46.9% 0.50% EC
44 Cogent Biosciences, Inc. 19240Q201 Mar 2026 1,009,396 +345,734 $38.9M +307.7% 0.48% EC
45 Arcellx, Inc. 03940C100 Mar 2026 335,814 +91,943 $38.6M +92.6% 0.47% EC
46 Terns Pharmaceuticals, Inc. 880881107 Mar 2026 713,848 +305,389 $37.6M +1126.9% 0.46% EC
47 Nuvalent, Inc. 670703107 Mar 2026 355,481 +92,138 $36.4M +59.9% 0.45% EC
48 Mirum Pharmaceuticals, Inc. 604749101 Mar 2026 392,677 +153,038 $36.3M +106.5% 0.45% EC
49 Tempus AI, Inc. 88023B103 Mar 2026 773,906 +206,714 $35.0M -23.6% 0.43% EC
50 Xenon Pharmaceuticals, Inc. 98420N105 Mar 2026 598,390 +162,016 $34.8M +98.6% 0.43% EC
51 Amicus Therapeutics, Inc. 03152W109 Mar 2026 2,307,725 +534,693 $33.4M +138.8% 0.41% EC
52 CRISPR Therapeutics AG N/A Mar 2026 663,733 NEW $31.6M — 0.39% EC
53 Apellis Pharmaceuticals, Inc. 03753U106 Mar 2026 778,245 +163,376 $31.3M +125.0% 0.39% EC
54 Apogee Therapeutics, Inc. 03770N101 Mar 2026 353,520 +136,480 $29.8M +245.1% 0.37% EC
55 Scholar Rock Holding Corp. 80706P103 Mar 2026 593,730 +156,810 $29.2M +79.4% 0.36% EC
56 ACADIA Pharmaceuticals, Inc. 004225108 Mar 2026 1,251,241 +264,275 $27.9M +32.2% 0.34% EC
57 Bruker Corp. 116794108 Mar 2026 764,342 +157,409 $27.6M +40.0% 0.34% EC
58 Crinetics Pharmaceuticals, Inc. 22663K107 Mar 2026 726,428 +212,856 $26.4M +23.3% 0.32% EC
59 CG oncology, Inc. 156944100 Mar 2026 379,295 +102,737 $25.7M +130.4% 0.32% EC
60 Spyre Therapeutics, Inc. 00773J202 Mar 2026 478,909 +177,524 $24.2M +378.2% 0.30% EC
61 Erasca, Inc. 29479A108 Mar 2026 1,384,399 +435,673 $22.4M +983.0% 0.28% EC
62 Tarsus Pharmaceuticals, Inc. 87650L103 Mar 2026 297,522 +70,121 $20.9M +54.4% 0.26% EC
63 Twist Bioscience Corp. 90184D100 Mar 2026 436,795 +97,212 $20.8M +117.2% 0.26% EC
64 Centessa Pharmaceuticals plc 152309100 Mar 2026 520,762 +165,959 $20.7M +140.4% 0.25% EC
65 Ideaya Biosciences, Inc. 45166A102 Mar 2026 615,636 +140,159 $20.5M +58.6% 0.25% EC
66 Denali Therapeutics, Inc. 24823R105 Mar 2026 1,055,210 +309,336 $20.3M +87.1% 0.25% EC
67 Travere Therapeutics, Inc. 89422G107 Mar 2026 674,600 +162,993 $20.0M +63.9% 0.25% EC
68 ImmunityBio, Inc. 45256X103 Mar 2026 2,572,701 +2,011,290 $19.7M +1328.8% 0.24% EC
69 Arcutis Biotherapeutics, Inc. 03969K108 Mar 2026 814,779 +198,591 $19.2M +65.3% 0.24% EC
70 Veracyte, Inc. 92337F107 Mar 2026 579,343 +126,112 $18.7M +19.9% 0.23% EC
71 Structure Therapeutics, Inc. 86366E106 Mar 2026 381,676 +146,308 $18.4M +179.1% 0.23% EC
72 Edgewise Therapeutics, Inc. 28036F105 Mar 2026 572,192 +132,604 $18.0M +152.8% 0.22% EC
73 10X Genomics, Inc. 88025U109 Mar 2026 841,716 +190,578 $17.9M +134.8% 0.22% EC
74 Legend Biotech Corp. 52490G102 Mar 2026 983,928 +231,507 $17.8M -27.5% 0.22% EC
75 Newamsterdam Pharma Co. NV N/A Mar 2026 537,784 NEW $17.2M — 0.21% EC
76 Vera Therapeutics, Inc. 92337R101 Mar 2026 419,778 +133,613 $16.9M +103.1% 0.21% EC
77 Dyne Therapeutics, Inc. 26818M108 Mar 2026 917,470 +271,040 $16.6M +103.4% 0.20% EC
78 Beam Therapeutics, Inc. 07373V105 Mar 2026 692,124 +154,035 $16.5M +26.3% 0.20% EC
79 BioCryst Pharmaceuticals, Inc. 09058V103 Mar 2026 1,715,826 +520,640 $16.3M +80.1% 0.20% EC
80 Kodiak Sciences, Inc. 50015M109 — 422,431 NEW $16.1M — 0.20% EC
81 Sarepta Therapeutics, Inc. 803607100 Mar 2026 739,607 +191,742 $16.1M +52.4% 0.20% EC
82 Caris Life Sciences, Inc. 142152107 — 898,011 NEW $16.1M — 0.20% EC
83 Immunovant, Inc. 45258J102 Mar 2026 626,211 +209,952 $15.6M +131.8% 0.19% EC
84 ADMA Biologics, Inc. 000899104 Mar 2026 1,711,239 +352,475 $15.4M -22.6% 0.19% EC
85 Adaptive Biotechnologies Corp. 00650F109 Mar 2026 1,105,997 +249,550 $15.4M +19.8% 0.19% EC
86 Summit Therapeutics, Inc. 86627T108 Mar 2026 799,477 +138,225 $15.2M +11.0% 0.19% EC
87 Oruka Therapeutics, Inc. 687604108 Mar 2026 304,331 +123,392 $14.9M +329.0% 0.18% EC
88 Syndax Pharmaceuticals, Inc. 87164F105 Mar 2026 631,524 +140,056 $14.8M +95.1% 0.18% EC
89 Tango Therapeutics, Inc. 87583X109 Mar 2026 687,885 +303,039 $14.4M +345.2% 0.18% EC
90 Ultragenyx Pharmaceutical, Inc. 90400D108 Mar 2026 680,286 +151,750 $14.3M -10.4% 0.18% EC
91 Disc Medicine, Inc. 254604101 Mar 2026 214,889 +79,464 $13.7M +53.5% 0.17% EC
92 Agios Pharmaceuticals, Inc. 00847X104 Mar 2026 400,087 +79,413 $13.5M +5.2% 0.17% EC
93 GRAIL, Inc. 384747101 Mar 2026 261,045 +84,904 $13.5M +29.5% 0.17% EC
94 Definium Therapeutics, Inc. 24477V105 — 703,030 NEW $13.3M — 0.16% EC
95 Zymeworks, Inc. 98985Y108 Mar 2026 529,981 +99,818 $13.3M +80.6% 0.16% EC
96 Arcus Biosciences, Inc. 03969F109 Mar 2026 612,355 +226,556 $13.2M +152.1% 0.16% EC
97 BlackRock Funds III 066922477 Mar 2026 12,996,156 +1,865,974 $13.0M +16.8% 0.16% STIV
98 Aurinia Pharmaceuticals, Inc. 05156V102 Mar 2026 874,336 +173,978 $13.0M +67.4% 0.16% EC
99 Enliven Therapeutics, Inc. 29337E102 Mar 2026 322,556 +97,642 $12.6M +174.6% 0.16% EC
100 Day One Biopharmaceuticals, Inc. 23954D109 Mar 2026 578,773 +138,686 $12.4M +299.9% 0.15% EC
101 Vericel Corp. 92346J108 Mar 2026 373,502 +79,186 $12.0M +29.7% 0.15% EC
102 Mineralys Therapeutics, Inc. 603170101 Mar 2026 439,648 +188,451 $11.9M +25.0% 0.15% EC
103 Alumis, Inc. 022307102 Mar 2026 530,358 +136,492 $11.7M +643.5% 0.14% EC
104 Zai Lab Ltd. 98887Q104 Mar 2026 613,747 +158,245 $11.5M -25.2% 0.14% EC
105 Nurix Therapeutics, Inc. 67080M103 Mar 2026 720,848 +279,011 $11.2M +173.7% 0.14% EC
106 Stoke Therapeutics, Inc. 86150R107 Mar 2026 331,288 +60,509 $10.8M +69.5% 0.13% EC
107 Intellia Therapeutics, Inc. 45826J105 Mar 2026 835,337 +239,413 $10.7M +4.1% 0.13% EC
108 AnaptysBio, Inc. 032724106 Mar 2026 192,136 +41,248 $10.7M +130.6% 0.13% EC
109 Recursion Pharmaceuticals, Inc. 75629V104 Mar 2026 3,419,857 +1,456,251 $10.5M +9.6% 0.13% EC
110 Tyra Biosciences, Inc. 90240B106 Mar 2026 272,474 +75,596 $10.4M +278.9% 0.13% EC
111 Relay Therapeutics, Inc. 75943R102 Mar 2026 980,266 +212,887 $9.8M +143.5% 0.12% EC
112 Amylyx Pharmaceuticals, Inc. 03237H101 Mar 2026 687,536 +295,304 $9.6M +79.3% 0.12% EC
113 Novavax, Inc. 670002401 Mar 2026 1,157,114 +284,679 $9.4M +24.5% 0.12% EC
114 Iovance Biotherapeutics, Inc. 462260100 Mar 2026 2,619,021 +892,738 $9.2M +145.4% 0.11% EC
115 WaVe Life Sciences Ltd. N/A Mar 2026 1,176,186 NEW $8.5M — 0.10% EC
116 Immunocore Holdings plc 45258D105 Mar 2026 277,185 +69,042 $8.4M +10.5% 0.10% EC
117 Novocure Ltd. N/A Mar 2026 763,201 NEW $8.3M — 0.10% EC
118 Galapagos NV 36315X101 Mar 2026 271,893 +67,142 $8.2M +15.0% 0.10% EC
119 Grifols SA 398438408 Mar 2026 976,161 +260,751 $7.8M +9.9% 0.10% EC
120 Biohaven Ltd. N/A Mar 2026 917,535 NEW $7.8M — 0.10% EC
121 Nuvation Bio, Inc. 67080N101 Mar 2026 1,795,888 +438,463 $7.7M +53.4% 0.09% EC
122 AtaiBeckley, Inc. 04650F101 — 2,160,067 NEW $7.6M — 0.09% EC
123 Taysha Gene Therapies, Inc. 877619106 Mar 2026 1,672,180 +365,284 $7.5M +74.9% 0.09% EC
124 Sionna Therapeutics, Inc. 829401108 — 185,101 NEW $7.4M — 0.09% EC
125 Trevi Therapeutics, Inc. 89532M101 Mar 2026 608,481 +132,280 $7.3M +66.6% 0.09% EC
126 Mesoblast Ltd. 590717401 Mar 2026 460,143 +75,080 $7.1M +14.1% 0.09% EC
127 Corvus Pharmaceuticals, Inc. 221015100 Mar 2026 473,326 +147,124 $6.9M +188.0% 0.09% EC
128 Olema Pharmaceuticals, Inc. 68062P106 Mar 2026 457,751 +146,215 $6.8M +123.8% 0.08% EC
129 Rapport Therapeutics, Inc. 75383L102 Mar 2026 217,759 +114,792 $6.8M +122.8% 0.08% EC
130 uniQure NV N/A Mar 2026 413,699 NEW $6.8M — 0.08% EC
131 Geron Corp. 374163103 Mar 2026 4,513,103 +949,653 $6.7M +37.7% 0.08% EC
132 Fortrea Holdings, Inc. 34965K107 Mar 2026 693,057 +160,366 $6.5M +45.6% 0.08% EC
133 Vir Biotechnology, Inc. 92764N102 Mar 2026 704,449 +176,192 $6.3M +109.3% 0.08% EC
134 Xencor, Inc. 98401F105 Mar 2026 513,267 +118,251 $6.2M +33.6% 0.08% EC
135 AbCellera Biologics, Inc. 00288U106 Mar 2026 1,732,022 +402,852 $6.0M -9.6% 0.07% EC
136 MBX Biosciences, Inc. 55287L101 — 199,599 NEW $6.0M — 0.07% EC
137 Maze Therapeutics, Inc. 578784100 — 197,936 NEW $5.9M — 0.07% EC
138 CareDx, Inc. 14167L103 Mar 2026 337,886 +45,219 $5.9M +37.8% 0.07% EC
139 Theravance Biopharma, Inc. N/A Mar 2026 353,652 NEW $5.7M — 0.07% EC
140 Monte Rosa Therapeutics, Inc. 61225M102 Mar 2026 346,430 +74,368 $5.7M +182.7% 0.07% EC
141 KalVista Pharmaceuticals, Inc. 483497103 Mar 2026 276,916 +56,092 $5.6M +107.3% 0.07% EC
142 Janux Therapeutics, Inc. 47103J105 Mar 2026 392,349 +73,384 $5.5M -30.0% 0.07% EC
143 Pharvaris NV N/A Mar 2026 191,961 NEW $5.4M — 0.07% EC
144 MannKind Corp. 56400P706 Mar 2026 2,199,381 +442,447 $5.4M -42.9% 0.07% EC
145 ORIC Pharmaceuticals, Inc. 68622P109 Mar 2026 424,422 +94,873 $5.4M +36.0% 0.07% EC
146 Castle Biosciences, Inc. 14843C105 Mar 2026 215,689 +49,568 $5.3M +40.0% 0.07% EC
147 Annexon, Inc. 03589W102 Mar 2026 952,884 +391,819 $5.3M +208.5% 0.06% EC
148 UroGen Pharma Ltd. N/A Mar 2026 286,041 NEW $5.1M — 0.06% EC
149 Kura Oncology, Inc. 50127T109 Mar 2026 628,449 +132,190 $5.1M +16.3% 0.06% EC
150 Inhibrx Biosciences, Inc. 45720N103 Mar 2026 75,835 +17,678 $5.1M +160.3% 0.06% EC
151 Stevanato Group SpA N/A Mar 2026 370,391 NEW $5.1M — 0.06% EC
152 Arbutus Biopharma Corp. 03879J100 Mar 2026 1,119,437 +242,128 $5.0M +26.5% 0.06% EC
153 Septerna, Inc. 81734D104 — 200,845 NEW $4.8M — 0.06% EC
154 Alto Neuroscience, Inc. 02157Q109 — 212,677 NEW $4.8M — 0.06% EC
155 Bicara Therapeutics, Inc. 055477103 — 236,865 NEW $4.7M — 0.06% EC
156 GH Research plc N/A Mar 2026 334,162 NEW $4.7M — 0.06% EC
157 ArriVent Biopharma, Inc. 04272N102 Mar 2026 201,242 +25,364 $4.6M +43.1% 0.06% EC
158 CytomX Therapeutics, Inc. 23284F105 — 987,397 NEW $4.6M — 0.06% EC
159 Cullinan Therapeutics, Inc. 230031106 Mar 2026 323,429 +103,790 $4.6M +252.9% 0.06% EC
160 Replimune Group, Inc. 76029N106 Mar 2026 570,930 +193,631 $4.4M +176.3% 0.05% EC
161 Precigen, Inc. 74017N105 Mar 2026 1,104,713 +234,422 $4.3M +49.3% 0.05% EC
162 Arvinas, Inc. 04335A105 Mar 2026 403,100 +24,178 $4.3M +32.4% 0.05% EC
163 Savara, Inc. 805111101 Mar 2026 775,563 +297,421 $4.2M +148.1% 0.05% EC
164 Ironwood Pharmaceuticals, Inc. 46333X108 Mar 2026 1,173,471 +251,556 $4.1M +241.0% 0.05% EC
165 Phathom Pharmaceuticals, Inc. 71722W107 Mar 2026 356,945 +132,820 $4.0M +50.3% 0.05% EC
166 Zevra Therapeutics, Inc. 488445206 Mar 2026 413,742 +86,577 $3.9M +23.9% 0.05% EC
167 Cytek Biosciences, Inc. 23285D109 Mar 2026 868,726 +187,560 $3.8M +60.6% 0.05% EC
168 MeiraGTx Holdings plc N/A Mar 2026 430,643 NEW $3.7M — 0.05% EC
169 ARS Pharmaceuticals, Inc. 82835W108 Mar 2026 463,404 +124,031 $3.7M +9.1% 0.05% EC
170 BioAge Labs, Inc. 09077V100 — 211,362 NEW $3.7M — 0.05% EC
171 Sana Biotechnology, Inc. 799566104 Mar 2026 1,235,916 +383,395 $3.6M +17.6% 0.04% EC
172 Rigel Pharmaceuticals, Inc. 766559702 Mar 2026 131,031 +28,123 $3.5M +21.5% 0.04% EC
173 Zenas Biopharma, Inc. 98937L105 — 175,941 NEW $3.4M — 0.04% EC
174 Compass Pathways plc 20451W101 Mar 2026 612,150 +235,040 $3.4M +56.7% 0.04% EC
175 Fulcrum Therapeutics, Inc. 359616109 — 429,371 NEW $3.3M — 0.04% EC
176 OPKO Health, Inc. 68375N103 Mar 2026 2,882,600 +770,215 $3.3M +0.4% 0.04% EC
177 Solid Biosciences, Inc. 83422E204 Mar 2026 446,552 +100,535 $3.2M +50.6% 0.04% EC
178 4D Molecular Therapeutics, Inc. 35104E100 Mar 2026 338,744 +84,709 $3.2M +42.9% 0.04% EC
179 Prothena Corp. plc N/A Mar 2026 323,349 NEW $3.1M — 0.04% EC
180 Emergent BioSolutions, Inc. 29089Q105 Mar 2026 376,503 +75,513 $3.1M +17.7% 0.04% EC
181 Myriad Genetics, Inc. 62855J104 Mar 2026 662,895 +141,963 $3.0M -20.8% 0.04% EC
182 Absci Corp. 00091E109 Mar 2026 975,088 +204,457 $2.9M +24.9% 0.04% EC
183 BridgeBio Oncology Therapeutics, Inc. 107924102 — 324,513 NEW $2.9M — 0.04% EC
184 Perspective Therapeutics, Inc. 46489V302 Mar 2026 693,460 +335,293 $2.9M +135.4% 0.04% EC
185 Aclaris Therapeutics, Inc. 00461U105 — 766,012 NEW $2.9M — 0.04% EC
186 Altimmune, Inc. 02155H200 Mar 2026 926,610 +423,158 $2.9M +50.4% 0.04% EC
187 Vanda Pharmaceuticals, Inc. 921659108 Mar 2026 405,038 +80,628 $2.8M +72.9% 0.03% EC
188 Allogene Therapeutics, Inc. 019770106 Mar 2026 1,145,572 +231,657 $2.8M +146.7% 0.03% EC
189 REGENXBIO, Inc. 75901B107 Mar 2026 331,423 +61,506 $2.8M +6.6% 0.03% EC
190 Rocket Pharmaceuticals, Inc. 77313F106 Mar 2026 752,567 +169,564 $2.7M +41.8% 0.03% EC
191 Pacific Biosciences of California, Inc. 69404D108 Mar 2026 2,021,533 +462,422 $2.7M +33.7% 0.03% EC
192 Lexeo Therapeutics, Inc. 52886X107 Mar 2026 457,447 +186,991 $2.6M +46.2% 0.03% EC
193 Alvotech SA N/A Mar 2026 763,481 NEW $2.6M — 0.03% EC
194 Contineum Therapeutics, Inc. 21217B100 — 200,362 NEW $2.6M — 0.03% EC
195 Enanta Pharmaceuticals, Inc. 29251M106 Mar 2026 205,184 +89,528 $2.6M +87.2% 0.03% EC
196 Lineage Cell Therapeutics, Inc. 53566P109 — 1,621,430 NEW $2.6M — 0.03% EC
197 Standard BioTools, Inc. 34385P108 Mar 2026 2,747,556 +592,420 $2.5M -9.8% 0.03% EC
198 ADC Therapeutics SA N/A Mar 2026 673,142 NEW $2.5M — 0.03% EC
199 Design Therapeutics, Inc. 25056L103 Mar 2026 235,859 +52,200 $2.5M +81.5% 0.03% EC
200 Personalis, Inc. 71535D106 Mar 2026 393,153 +80,963 $2.5M +23.0% 0.03% EC
201 Atea Pharmaceuticals, Inc. 04683R106 Mar 2026 460,056 +80,920 $2.5M +125.1% 0.03% EC
202 Prime Medicine, Inc. 74168J101 Mar 2026 704,092 +147,403 $2.5M -20.6% 0.03% EC
203 Keros Therapeutics, Inc. 492327101 Mar 2026 214,789 +14,886 $2.4M -25.0% 0.03% EC
204 Fulgent Genetics, Inc. 359664109 Mar 2026 148,748 +32,402 $2.4M -10.1% 0.03% EC
205 Tectonic Therapeutic, Inc. 878972108 Mar 2026 75,889 +14,369 $2.3M +143.0% 0.03% EC
206 Aura Biosciences, Inc. 05153U107 Mar 2026 338,128 +93,190 $2.3M +49.4% 0.03% EC
207 Kyverna Therapeutics, Inc. 501976104 Mar 2026 251,263 +122,491 $2.2M +180.7% 0.03% EC
208 Maravai LifeSciences Holdings, Inc. 56600D107 Mar 2026 759,052 +149,573 $2.1M +22.8% 0.03% EC
209 Immuneering Corp. 45254E107 — 390,008 NEW $2.1M — 0.03% EC
210 Anavex Life Sciences Corp. 032797300 Mar 2026 668,447 +178,938 $2.1M -52.9% 0.03% EC
211 Entrada Therapeutics, Inc. 29384C108 Mar 2026 158,267 +21,061 $2.0M +151.0% 0.02% EC
212 Ginkgo Bioworks Holdings, Inc. 37611X209 Mar 2026 317,323 +78,444 $1.9M -44.1% 0.02% EC
213 Upstream Bio, Inc. 91678A107 — 213,032 NEW $1.9M — 0.02% EC
214 Neurogene, Inc. 64135M105 Mar 2026 94,694 +22,201 $1.9M +52.0% 0.02% EC
215 LENZ Therapeutics, Inc. 52635N103 Mar 2026 206,971 +65,220 $1.9M -71.3% 0.02% EC
216 Autolus Therapeutics plc 05280R100 Mar 2026 1,321,681 +321,286 $1.8M +11.9% 0.02% EC
217 Editas Medicine, Inc. 28106W103 Mar 2026 731,163 +219,510 $1.8M +1.7% 0.02% EC
218 Cabaletta Bio, Inc. 12674W109 — 633,353 NEW $1.7M — 0.02% EC
219 C4 Therapeutics, Inc. 12529R107 Mar 2026 608,839 +255,062 $1.6M +103.9% 0.02% EC
220 Larimar Therapeutics, Inc. 517125100 Mar 2026 350,415 +63,752 $1.6M +70.3% 0.02% EC
221 Candel Therapeutics, Inc. 137404109 — 294,995 NEW $1.4M — 0.02% EC
222 Arcturus Therapeutics Holdings, Inc. 03969T109 Mar 2026 186,967 +40,371 $1.4M -46.6% 0.02% EC
223 OmniAb, Inc. 68218J103 — 874,147 NEW $1.4M — 0.02% EC
224 NovaBridge Biosciences 44975P103 — 539,518 NEW $1.3M — 0.02% EC
225 Voyager Therapeutics, Inc. 92915B106 Mar 2026 329,043 +64,987 $1.3M +3.0% 0.02% EC
226 AC Immune SA N/A Mar 2026 443,438 NEW $1.2M — 0.02% EC
227 Bicycle Therapeutics plc 088786108 Mar 2026 244,101 +60,583 $1.1M -20.3% 0.01% EC
228 Caribou Biosciences, Inc. 142038108 — 594,484 NEW $1.1M — 0.01% EC
229 Codexis, Inc. 192005106 Mar 2026 683,417 +188,506 $1.1M -7.8% 0.01% EC
230 Lyell Immunopharma, Inc. 55083R203 Mar 2026 54,413 +3,623 $1.1M +32.3% 0.01% EC
231 Cellectis SA 15117K103 — 339,873 NEW $1.1M — 0.01% EC
232 Foghorn Therapeutics, Inc. 344174107 Mar 2026 223,190 +46,893 $1.1M +23.8% 0.01% EC
233 Quanterix Corp. 74766Q101 Mar 2026 284,827 +53,360 $1.0M -20.2% 0.01% EC
234 Sagimet Biosciences, Inc. 786700104 — 189,187 NEW $989K — 0.01% EC
235 Quantum-Si, Inc. 74765K105 — 1,223,534 NEW $947K — 0.01% EC
236 Silence Therapeutics plc 82686Q101 Mar 2026 173,313 +140,776 $913K +440.9% 0.01% EC
237 Tenaya Therapeutics, Inc. 87990A106 — 1,200,002 NEW $831K — 0.01% EC
238 Neumora Therapeutics, Inc. 640979100 Mar 2026 421,430 +13,311 $822K +10.6% 0.01% EC
239 PepGen, Inc. 713317105 Mar 2026 451,333 +274,004 $799K -2.5% 0.01% EC
240 Humacyte, Inc. 44486Q103 Mar 2026 1,222,120 +453,285 $741K -44.6% 0.01% EC
241 Black Diamond Therapeutics, Inc. 09203E105 — 321,542 NEW $685K — 0.01% EC
242 Pyxis Oncology, Inc. 747324101 Mar 2026 345,130 +89,826 $504K -11.1% 0.01% EC
243 Gossamer Bio, Inc. 38341P102 — 1,510,536 NEW $496K — 0.01% EC
244 Jyong Biotech Ltd. N/A Mar 2026 206,499 NEW $444K — 0.01% EC
245 Akero Therapeutics, Inc. 009CVR044 — 515,954 NEW $341K — 0.00% —
246 Aardvark Therapeutics, Inc. 002942100 — 89,682 NEW $338K — 0.00% EC
247 Immutep Ltd. 45257L108 Mar 2026 809,244 +215,082 $284K -72.7% 0.00% EC
248 Alpha Teknova, Inc. 02080L102 Mar 2026 79,636 +11,537 $230K -45.4% 0.00% EC
249 N/A N/A Mar 2026 33 NEW $56K — 0.00% DE
250 Contra Chinook Therape 169CVR016 Mar 2026 320,962 — $55K +0.0% 0.00% —
251 Cartesian Therapeutics, Inc. 816212112 Mar 2026 6,098 — $2K +4.0% 0.00% —
252 Fusion Pharmaceuticals, Inc. 361CVR012 Mar 2026 1,880 — $1K +0.0% 0.00% —
253 Cargo Therapeutics, Inc. 141CVR019 Mar 2026 198,104 — $2 +0.0% 0.00% —
254 Akouos, Inc. 009CVR036 Mar 2026 157,087 — $2 +0.0% 0.00% —
255 Third Harmonic Bio, Inc. 88427A107 Mar 2026 134,478 — $1 -100.0% 0.00% EC
256 OmniAb, Inc. 68218J301 Mar 2026 46,839 — $0 +0.0% 0.00% —
257 OmniAb Operations, Inc. 68218J202 Mar 2026 46,839 — $0 +0.0% 0.00% —
258 N/A N/A Mar 2026 53 NEW $-73747 — -0.00% DE
✕ IQVIA Holdings, Inc. 46266C105 — 993,636 SOLD $188.7M — — —
✕ Mettler-Toledo International, Inc. 592688105 — 120,598 SOLD $148.0M — — —
✕ Waters Corp. 941848103 — 350,226 SOLD $105.0M — — —
✕ Verona Pharma plc 925050106 — 326,745 SOLD $34.9M — — —
✕ Avidity Biosciences, Inc. 05370A108 — 683,841 SOLD $29.8M — — —
✕ Akero Therapeutics, Inc. 00973Y108 — 416,668 SOLD $19.8M — — —
✕ 89bio, Inc. 282559103 — 860,093 SOLD $12.6M — — —
✕ Dynavax Technologies Corp. 268158201 — 687,646 SOLD $6.8M — — —
✕ Evotec SE 30050E105 — 1,303,894 SOLD $4.7M — — —
✕ Tourmaline Bio, Inc. 89157D105 — 98,115 SOLD $4.7M — — —
✕ CorMedix, Inc. 21900C308 — 394,365 SOLD $4.6M — — —
✕ Astria Therapeutics, Inc. 04635X102 — 267,005 SOLD $1.9M — — —
✕ Alector, Inc. 014442107 — 459,305 SOLD $1.4M — — —
✕ MaxCyte, Inc. 57777K106 — 598,801 SOLD $0.9M — — —
✕ Fate Therapeutics, Inc. 31189P102 — 654,794 SOLD $0.8M — — —
✕ Climb Bio, Inc. 28658R106 — 366,108 SOLD $0.7M — — —
✕ Cybin, Inc. 23256X407 — 121,852 SOLD $0.7M — — —
✕ Nkarta, Inc. 65487U108 — 318,966 SOLD $0.7M — — —
✕ Biomea Fusion, Inc. 09077A106 — 306,014 SOLD $0.6M — — —
✕ MacroGenics, Inc. 556099109 — 348,613 SOLD $0.6M — — —
✕ Cartesian Therapeutics, Inc. 816212302 — 50,587 SOLD $0.5M — — —
✕ TScan Therapeutics, Inc. 89854M101 — 271,718 SOLD $0.5M — — —
✕ Pliant Therapeutics, Inc. 729139105 — 331,943 SOLD $0.5M — — —
✕ Applied Therapeutics, Inc. 03828A101 — 758,868 SOLD $0.5M — — —
✕ Sutro Biopharma, Inc. 869367102 — 483,483 SOLD $0.4M — — —
✕ Acrivon Therapeutics, Inc. 004890109 — 130,270 SOLD $0.2M — — —
✕ Tevogen Bio Holdings, Inc. 88165K101 — 260,788 SOLD $0.2M — — —
✕ Artiva Biotherapeutics, Inc. 04317A107 — 68,196 SOLD $0.2M — — —
✕ Mersana Therapeutics, Inc. 59045L205 — 24,758 SOLD $0.2M — — —
✕ OnKure Therapeutics, Inc. 68277Q105 — 53,057 SOLD $0.1M — — —
✕ Q32 Bio, Inc. 746964105 — 25,036 SOLD $0.0M — — —